-
-
-
-
-
-
-
Amneal Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
Amneal Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
Amneal Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
-
-
-
-
-
-
-
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
-
-
-
-
-
-
-
Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023
-
1,199,225 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


